These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30444834)

  • 1. Neurostimulation-guided Anal Intrasphincteric Botulinum Toxin Injection in Children With Hirschsprung Disease.
    Louis-Borrione C; Faure A; Garnier S; Guys JM; Merrot T; Héry G; Dariel A
    J Pediatr Gastroenterol Nutr; 2019 Apr; 68(4):527-532. PubMed ID: 30444834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcome after anal intrasphincteric Botox injection in children with surgically treated Hirschsprung disease.
    Han-Geurts IJ; Hendrix VC; de Blaauw I; Wijnen MH; van Heurn EL
    J Pediatr Gastroenterol Nutr; 2014 Nov; 59(5):604-7. PubMed ID: 25000353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultrasound-guided intrasphincteric botulinum toxin injection relieves obstructive defecation due to Hirschsprung's disease and internal anal sphincter achalasia.
    Church JT; Gadepalli SK; Talishinsky T; Teitelbaum DH; Jarboe MD
    J Pediatr Surg; 2017 Jan; 52(1):74-78. PubMed ID: 27836361
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin is efficient to treat obstructive symptoms in children with Hirschsprung disease.
    Wester T; Granström AL
    Pediatr Surg Int; 2015 Mar; 31(3):255-9. PubMed ID: 25616563
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term clinical outcome after botulinum toxin injection in children with nonrelaxing internal anal sphincter.
    Chumpitazi BP; Fishman SJ; Nurko S
    Am J Gastroenterol; 2009 Apr; 104(4):976-83. PubMed ID: 19259081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrasphincteric botulinum toxin injections for post-operative obstructive defecation problems in Hirschsprung disease: A retrospective observational study.
    Roorda D; Oosterlaan J; van Heurn E; Derikx J
    J Pediatr Surg; 2021 Aug; 56(8):1342-1348. PubMed ID: 33288128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of rectal biopsy in predicting response to intrasphincteric botulinum toxin injection for obstructive symptoms after a pullthrough operation.
    Hosseini SM; Foroutan HR; Bahador A; Khosravi MB; Geramizadeh B; Sabet B; Zeraatian S; Razmi T; Banani SJ
    Indian J Gastroenterol; 2008; 27(3):99-102. PubMed ID: 18787278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin injections after surgery for Hirschsprung disease: Systematic review and meta-analysis.
    Roorda D; Abeln ZA; Oosterlaan J; van Heurn LW; Derikx JP
    World J Gastroenterol; 2019 Jul; 25(25):3268-3280. PubMed ID: 31333317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botox injection treatment for anal outlet obstruction in patients with internal anal sphincter achalasia and Hirschsprung's disease.
    Koivusalo AI; Pakarinen MP; Rintala RJ
    Pediatr Surg Int; 2009 Oct; 25(10):873-6. PubMed ID: 19662428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrasphincteric botulinum toxin decreases the rate of hospitalization for postoperative obstructive symptoms in children with Hirschsprung disease.
    Patrus B; Nasr A; Langer JC; Gerstle JT
    J Pediatr Surg; 2011 Jan; 46(1):184-7. PubMed ID: 21238663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin injection for internal anal sphincter achalasia after pull-through surgery in Hirschsprung disease.
    Youn JK; Han JW; Oh C; Kim SY; Jung SE; Kim HY
    Medicine (Baltimore); 2019 Nov; 98(45):e17855. PubMed ID: 31702647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective study of botulinum toxin for internal anal sphincter hypertonicity in children with Hirschsprung's disease.
    Minkes RK; Langer JC
    J Pediatr Surg; 2000 Dec; 35(12):1733-6. PubMed ID: 11101725
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fissurectomy Combined with High-Dose Botulinum Toxin Is a Safe and Effective Treatment for Chronic Anal Fissure and a Promising Alternative to Surgical Sphincterotomy.
    Barnes TG; Zafrani Z; Abdelrazeq AS
    Dis Colon Rectum; 2015 Oct; 58(10):967-73. PubMed ID: 26347969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Internal anal sphincter achalasia in children: clinical characteristics and treatment with Clostridium botulinum toxin.
    Ciamarra P; Nurko S; Barksdale E; Fishman S; Di Lorenzo C
    J Pediatr Gastroenterol Nutr; 2003 Sep; 37(3):315-9. PubMed ID: 12960655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrasphincteric Botox injections in Hirschsprung's disease: indications and outcome in 64 procedures over a ten-year period.
    Pini Prato A; Faticato MG; Mazzola C; Arrigo S; Mattioli G; Arnoldi R; Mosconi M
    Minerva Pediatr (Torino); 2023 Aug; 75(4):482-489. PubMed ID: 30419742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin injection for childhood constipation is safe and can be effective regardless of anal sphincter dynamics.
    Zar-Kessler C; Kuo B; Belkind-Gerson J
    J Pediatr Surg; 2018 Apr; 53(4):693-697. PubMed ID: 29395154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional outcomes in Hirschsprung disease: A single institution's 12-year experience.
    Thakkar HS; Bassett C; Hsu A; Manuele R; Kufeji D; Richards CA; Agrawal M; Keshtgar AS
    J Pediatr Surg; 2017 Feb; 52(2):277-280. PubMed ID: 27912977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histology and function of the internal anal sphincter after injection of botulinum toxin.
    Langer JC; Birnbaum EE; Schmidt RE
    J Surg Res; 1997 Dec; 73(2):113-6. PubMed ID: 9441803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anal sphincter botulinum toxin injection in children with functional anorectal and colonic disorders: A large institutional study and review of the literature focusing on complications.
    Halleran DR; Lu PL; Ahmad H; Paradiso MM; Lehmkuhl H; Akers A; Hallagan A; Bali N; Vaz K; Yacob D; Di Lorenzo C; Levitt MA; Wood RJ
    J Pediatr Surg; 2019 Nov; 54(11):2305-2310. PubMed ID: 31060739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preliminary experience with intrasphincteric botulinum toxin for persistent constipation after pull-through for Hirschsprung's disease.
    Langer JC; Birnbaum E
    J Pediatr Surg; 1997 Jul; 32(7):1059-61; discussion 1061-2. PubMed ID: 9247234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.